Skip to content
Peptide Therapeutics intermediate

ALS: Oligopeptide Research Reference

Progressive motor neuron disease affecting both upper (cortical) and lower (spinal) motor neurons. Sporadic (90%) or familial (10%, SOD1, C9orf72, TARDBP, FU...

By Encyclopeptide Editorial | 1 min read
amyotrophic-lateral-sclerosis peptide research

Overview

Progressive motor neuron disease affecting both upper (cortical) and lower (spinal) motor neurons. Sporadic (90%) or familial (10%, SOD1, C9orf72, TARDBP, FU…ess, atrophy, fasciculations, spasticity. Mean survival 3-5 years from diagnosis. Treatments: riluzole (extends survival 2-3 months), edaravone (slows decline), tofersen (SOD1 mutations), sodium phenylbutyrate/taurursodiol.

Clinical Significance

This molecule has important therapeutic or diagnostic applications in clinical medicine.

References

  1. Encyclopeptide Database. “ALS” monograph. encyclopeptide.com.

Test Your Knowledge

Reinforce what you learned about ALS: Oligopeptide Research Reference with interactive quizzes on Wikipept.

Take a Quiz on Wikipept